Brief: Xintela Obtains U.S. Patent For Stem Cell Treatment

Xintela AB

06/12/2022 14:58

Dec 6 (Reuters) - Xintela AB  XINT.ST :
    * XINTELA OBTAINS US PATENT FOR STEM CELL TREATMENT
    * US PATENT OFFICE USPTO HAS TODAY APPROVED COMPANY'S PATENT
APPLICATION FOR TREATMENT OF MUSCULOSKELETAL DISEASES USING
XINTELA'S STEM CELL PRODUCTS
    * PATENT IS VALID UNTIL YEAR 2039

Source text for Eikon:  ID:nMFNxrpwD 
Further company coverage:  XINT.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))